Skip to main content

Baird Financial Group, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1648711 MILWAUKEE, WI

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$44,495,563
+$6,002,407 QoQ
Shares Held
57,589
+15.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 71.0448175866919.ToString("F0")% Shared 28.79716612547535.ToString("F0")% None 0.15801628783274582.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Baird Financial Group, Inc. holds $190,822,781 across 25 Biotechnology names. REGN ranks #2 (23.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
57,589 $44,495,563

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $44,495,563 57,589
2025-12-31 $38,493,156 49,870
2025-09-30 $27,205,996 48,386
2025-06-30 $25,713,975 48,979
2025-03-31 $28,284,120 44,596
2024-12-31 $24,727,110 34,713
2024-09-30 $37,684,850 35,848
2024-06-30 $36,463,383 34,693
2024-03-31 $32,659,209 33,932
2023-12-31 $29,739,776 33,861
2023-09-30 $27,656,393 33,606
2023-06-30 $23,935,285 33,311
2023-03-31 $25,821,800 31,426
2022-12-31 $25,605,678 35,490
2022-09-30 $24,464,528 35,514
2022-06-30 $21,868,853 36,995
2022-03-31 $25,512,583 36,529
2021-12-31 $11,483,559 18,184
2021-09-30 $11,679,973 19,300
2021-06-30 $8,504,887 15,227
2021-03-31 $6,041,524 12,769
2020-12-31 $4,094,839 8,476
2020-09-30 $4,498,951 8,037
2020-06-30 $4,818,942 7,727
2020-03-31 $3,938,546 8,066